FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 262 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Making a startup out of a scientist April 26, 2023 ESMO Calls for Cancer Care Safeguards in the EU’s Health Crisis... November 11, 2025 It Might Sound Trite But… May 11, 2021 We’re asking scientists to tackle 9 of the toughest challenges in... October 14, 2020 Load more HOT NEWS 5-Yr-Old Cancer Survivor Used His Birthday To Collect Toys For Sick... For HPV-Positive Women, Test Can Guide Cervical Cancer Screening Follow-Up Farmer With Stage IV Cancer Is Too Sick To Harvest Crops... What to Know About Getting Access to New Cancer Advances Presented...
